6. Familial tumour syndromes Flashcards
Definition of familial tumour syndromes
Also known as neurocutaneous syndromes; tumours/hamartomas found in skin & nervous system; often autosomal dominant inheritance
Types of familial tumour syndromes
- Neurofibromatosis-1
- Neurofibromatosis-2
- Tuberous sclerosis
- Von hippel-lindau syndrome
Features of neurofibromatosis-1
- Neural tumours: neurofibroma (skin, VII nerve, spinal cord nerve roots), meningioma, optic nerve glioma, pheochromocytoma
- Cutaneous, musculoskeletal & renal abnormalities
- Risk of sarcomatous transformation of
neurofibromas → malignant nerve sheath tumours
Molecular pathogenesis of neurofibromatosis-1
Loss of 17q (NF-1 gene) which encodes neurofibromin (tumour suppressor regulating signal transduction)
Features of neurofibromatosis-2
Neural tumours: VIII nerve Schwannoma, meningioma, ependymomas of spinal cord
Molecular pathogenesis of neurofibromatosis-2
Loss of 22q (NF-2 gene) which encodes merlin
tumour suppressor regulating membrane receptor signaling, including contact inhibition
Features of tuberous sclerosis
- Brain: cortical tubers & hamartomas
- Renal angiomyolipomas
- Skin lesions: adenoma sebaceum, shagreen patch, ungula fibromas
- Lung lesions
Molecular pathogenesis of tuberous sclerosis
TSC 1 (encodes hamartin) & TSC 2 (encodes tuberin) genes, whose protein products combine to form a complex which inhibits the kinase mTOR (responsible for controlling protein synthesis & cell size)
Features of von-hippel-lindau syndrome
- Hemangioblastomas affecting cerebellum & retina
- Renal cell carcinoma
- Pheochromocytoma
- Endolymphatic sac tumour (inner ear)
- Cysts involving pancreas, liver, kidneys, adrenals
Molecular pathogenesis of von-hippel-lindau syndrome
VHL gene (3p25-p26) which encodes pVHL, a tumour suppressor that is a component of a ubiquitin ligase complex responsible for the downregulation of hypoxia-induced factor 1
Morphology of von-hippel-lindau syndrome
- Grossly: tumour stuck onto meninges
2. Histologically: psammoma bodies